Skip to main content

Table 3 Univariate cox regression analysis of SLC2 family genes for OS and DFS

From: Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data

Genea

OS

DFS

HR (95% CI)

P valueb

HR (95% CI)

P valueb

SLC2A1

1.13 (0.91–1.39)

0.271

1.28 (1.04–1.57)

0.018

SLC2A2

0.82 (0.61–1.09)

0.169

0.99 (0.8–1.24)

0.957

SLC2A3

1.33 (1.06–1.66)

0.013

1.32 (1.06–1.64)

0.014

SLC2A4

1.12 (0.9–1.39)

0.302

1.02 (0.82–1.27)

0.864

SLC2A5

1.17 (0.94–1.47)

0.159

1.04 (0.84–1.29)

0.703

SLC2A6

1.24 (1–1.54)

0.048

1.07 (0.87–1.32)

0.503

SLC2A7

1.23 (1.03–1.46)

0.019

1.06 (0.87–1.29)

0.562

SLC2A8

0.82 (0.67–1.01)

0.066

0.95 (0.78–1.17)

0.646

SLC2A9

0.86 (0.7–1.05)

0.135

1.00 (0.82–1.23)

0.965

SLC2A10

0.94 (0.76–1.17)

0.597

1.02 (0.82–1.27)

0.876

SLC2A11

1.14 (0.9–1.43)

0.277

1.11 (0.88–1.4)

0.369

SLC2A12

1.05 (0.84–1.32)

0.643

1.06 (0.86–1.32)

0.574

SLC2A13

0.89 (0.71–1.11)

0.305

1.02 (0.82–1.27)

0.835

SLC2A14

1.19 (0.96–1.49)

0.115

1.18 (0.96–1.46)

0.123

  1. Abbreviations: HR, hazard ratio; CI, confidence interval
  2. aUnit of measure is log2 of gene expression intensity
  3. bCalculated using the Wald test